Our results so far indicate that IL-1β is produced and exerts its protective effect in the early phase of the infection, but morbidity and mortality starts to become apparent in infected Il-1r1-/- mice only in the second week post-infection when mice definitively loose the ability to contain the infection and bacteria burden dramatically increase. Here, IL1B is linked to infection.